157 related articles for article (PubMed ID: 34193458)
1. Dietary omega 3 fatty acids for migraine.
Burch R
BMJ; 2021 Jun; 374():n1535. PubMed ID: 34193458
[No Abstract] [Full Text] [Related]
2. The Combined Effects of ω -3 Fatty Acids and Nano-Curcumin Supplementation on Intercellular Adhesion Molecule-1 (ICAM-1) Gene Expression and Serum Levels in Migraine Patients.
Soveyd N; Abdolahi M; Djalali M; Hatami M; Tafakhori A; Sarraf P; Honarvar NM
CNS Neurol Disord Drug Targets; 2018 Mar; 16(10):1120-1126. PubMed ID: 29237386
[TBL] [Abstract][Full Text] [Related]
3. Clinical inquiries. What dietary modifications are indicated for migraines?
Crawford P; Simmons M; Hoock J
J Fam Pract; 2006 Jan; 55(1):62-3, 66. PubMed ID: 16388771
[No Abstract] [Full Text] [Related]
4. A double- blind, randomized, and placebo-controlled clinical trial with omega-3 polyunsaturated fatty acids (OPFA ɷ-3) for the prevention of migraine in chronic migraine patients using amitriptyline.
Soares AA; Louçana PMC; Nasi EP; Sousa KMH; Sá OMS; Silva-Néto RP
Nutr Neurosci; 2018 Apr; 21(3):219-223. PubMed ID: 28056704
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of omega-3 fatty acids in migraine: A narrative review.
Cardia L; Calapai F; Mondello C; Quattrone D; Elisa Sorbara E; Mannucci C; Calapai G; Mondello E
Medicine (Baltimore); 2020 Oct; 99(42):e22253. PubMed ID: 33080672
[TBL] [Abstract][Full Text] [Related]
6. Effects of omega-3 fatty acids on the frequency, severity, and duration of migraine attacks: A systematic review and meta-analysis of randomized controlled trials.
Maghsoumi-Norouzabad L; Mansoori A; Abed R; Shishehbor F
Nutr Neurosci; 2018 Nov; 21(9):614-623. PubMed ID: 28665211
[TBL] [Abstract][Full Text] [Related]
7. A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.
Abdolahi M; Sarraf P; Javanbakht MH; Honarvar NM; Hatami M; Soveyd N; Tafakhori A; Sedighiyan M; Djalali M; Jafarieh A; Masoudian Y; Djalali M
CNS Neurol Disord Drug Targets; 2018; 17(6):430-438. PubMed ID: 29938621
[TBL] [Abstract][Full Text] [Related]
8. The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms.
Abdolahi M; Jafarieh A; Sarraf P; Sedighiyan M; Yousefi A; Tafakhori A; Abdollahi H; Salehinia F; Djalali M
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):874-884. PubMed ID: 30760195
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.
Abdolahi M; Tafakhori A; Togha M; Okhovat AA; Siassi F; Eshraghian MR; Sedighiyan M; Djalali M; Mohammadzadeh Honarvar N; Djalali M
Immunogenetics; 2017 Jun; 69(6):371-378. PubMed ID: 28478481
[TBL] [Abstract][Full Text] [Related]
10. Dietary suggestions for migraine prevention.
Murray KA; O'Neal KS; Weisz M
Am J Health Syst Pharm; 2015 Apr; 72(7):519-21. PubMed ID: 25788504
[No Abstract] [Full Text] [Related]
11. Response to dietary restrictions in migraine: a comparison of results in children and adults.
Berg MM; Braham J
Postgrad Med J; 1994 Dec; 70(830):937-8. PubMed ID: 7870648
[No Abstract] [Full Text] [Related]
12. Association of diet and headache.
Razeghi Jahromi S; Ghorbani Z; Martelletti P; Lampl C; Togha M;
J Headache Pain; 2019 Nov; 20(1):106. PubMed ID: 31726975
[TBL] [Abstract][Full Text] [Related]
13. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation].
Sempels C; Sienaert P
Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids and mood disorders.
Parker G; Gibson NA; Brotchie H; Heruc G; Rees AM; Hadzi-Pavlovic D
Am J Psychiatry; 2006 Jun; 163(6):969-78. PubMed ID: 16741195
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids in major depressive disorder.
Freeman MP
J Clin Psychiatry; 2009; 70 Suppl 5():7-11. PubMed ID: 19909687
[TBL] [Abstract][Full Text] [Related]
16. Dietary omega 3 and omega 6 fatty acids and cardiovascular responses to pressor and depressor stimuli.
Mills DE
World Rev Nutr Diet; 1991; 66():349-57. PubMed ID: 1905088
[No Abstract] [Full Text] [Related]
17. Are fish oils an effective therapy in mental illness--an analysis of the data.
Maidment ID
Acta Psychiatr Scand; 2000 Jul; 102(1):3-11. PubMed ID: 10892603
[TBL] [Abstract][Full Text] [Related]
18. The use of omega-3 fatty acids in mental illness.
Gören JL; Tewksbury AT
J Pharm Pract; 2011 Oct; 24(5):452-71. PubMed ID: 21940602
[TBL] [Abstract][Full Text] [Related]
19. Long-chain omega-3 fatty acids and headache in the U.S. population.
Sanders AE; Shaikh SR; Slade GD
Prostaglandins Leukot Essent Fatty Acids; 2018 Aug; 135():47-53. PubMed ID: 30103932
[TBL] [Abstract][Full Text] [Related]
20. Do omega-3 fatty acids help in depression?
Drug Ther Bull; 2007 Feb; 45(2):9-12. PubMed ID: 17357473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
